Context-Dependent Regulation of Type17 Immunity by Microbiota at the Intestinal Barrier

키워드

참고문헌 (166)

1. Duerkop BA, "Immune responses to the microbiota at the intestinal mucosal surface", Immunity, 31, pp.368~376 (2009)
2. Kayama H, "Interaction between the microbiota, epithelia, and immune cells in the intestine", Annu Rev Immunol, 38, pp.23~48 (2020)
3. Belkaid Y, "Homeostatic immunity and the microbiota", Immunity, 46, pp.562~576 (2017)
4. Zheng D, "Interaction between microbiota and immunity in health and disease", Cell Res, 30, pp.492~506 (2020)
5. Ansaldo E, "Control of immunity by the microbiota", Annu Rev Immunol, 39, pp.449~479 (2021)
6. Honda K, "The microbiota in adaptive immune homeostasis and disease", Nature, 535, pp.75~84 (2016)
7. Hacquard S, "Microbiota and host nutrition across plant and animal kingdoms", Cell Host Microbe, 17, pp.603~616 (2015)
8. Lynch JB, "Microbiomes as sources of emergent host phenotypes", Science, 365, pp.1405~1409 (2019)
9. Maynard CL, "Reciprocal interactions of the intestinal microbiota and immune system", Nature, 489, pp.231~241 (2012)
10. Kayama H, "Regulation of intestinal homeostasis by innate and adaptive immunity", Int Immunol, 24, pp.673~680 (2012)
11. Sun M, "Regulatory immune cells in regulation of intestinal inflammatory response to microbiota", Mucosal Immunol, 8, pp.969~978 (2015)
12. Zhang M, "Interactions between intestinal microbiota and host immune response in inflammatory bowel disease", Front Immunol, 8, pp.942~ (2017)
13. Kang M, "Microbiome and colorectal cancer : Unraveling host-microbiota interactions in colitisassociated colorectal cancer development", Semin Immunol, 32, pp.3~13 (2017)
14. Gopalakrishnan V, "The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy", Cancer Cell, 33, pp.570~580 (2018)
15. Happel KI, "Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae", J Exp Med, 202, pp.761~769 (2005)
16. Nakamoto N, "Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis", Nat Microbiol, 4, pp.492~503 (2019)
17. Puel A, "Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity", Science, 332, pp.65~68 (2011)
18. Okada S, "IMMUNODEFICIENCIES. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations", Science, 349, pp.606~613 (2015)
19. Lin X, "IL-17RA-signaling in Lgr5+ intestinal stem cells induces expression of transcription factor ATOH1 to promote secretory cell lineage commitment", Immunity, 55, pp.237~253 (2022)
20. Stockinger B, "The dichotomous nature of T helper 17 cells", Nat Rev Immunol, 17, pp.535~544 (2017)
21. Wang K, "The IL-23 to IL-17 cascade inflammation-related cancers", Clin Exp Rheumatol, 33(Suppl 92), pp.S87~S90 (2015)
22. Miossec P, "Targeting IL-17 and TH17 cells in chronic inflammation", Nat Rev Drug Discov, 11, pp.763~776 (2012)
23. Wang K, "Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis", Immunity, 41, pp.1052~1063 (2014)
24. Belkaid Y, "Role of the microbiota in immunity and inflammation", Cell, 157, pp.121~141 (2014)
25. Tan TG, "Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17cells in mice", Proc Natl Acad Sci U S A, 113, pp.E8141~E8150 (2016)
26. Ivanov II, "Induction of intestinal Th17 cells by segmented filamentous bacteria", Cell, 139, pp.485~498 (2009)
27. Ivanov II, "Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine", Cell Host Microbe, 4, pp.337~349 (2008)
28. Lathrop SK, "Peripheral education of the immune system by colonic commensal microbiota", Nature, 478, pp.250~254 (2011)
29. Ohnmacht C, "The microbiota regulates type 2 immunity through RORγt+ T cells", Science, 349, pp.989~993 (2015)
30. Sefik E, "Individual intestinal symbionts induce a distinct population of RORγ+ regulatory T cells", Science, 349, pp.993~997 (2015)
31. Atarashi K, "Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota", Nature, 500, pp.232~236 (2013)
32. Atarashi K, "Th17 cell induction by adhesion of microbes to intestinal epithelial cells", Cell, 163, pp.367~380 (2015)
33. Britton GJ, "Microbiotas from humans with inflammatory bowel disease alter the balance of gut Th17 and RORγt+regulatory T cells and exacerbate colitis in mice", Immunity, 50, pp.212~224 (2019)
34. Van Kaer L, "The response of CD1d-restricted invariant NKT cells to microbial pathogens and their products", Front Immunol, 6, pp.226~ (2015)
35. Howson LJ, "MR1-restricted mucosal-associated invariant T cells and their activation during infectious diseases", Front Immunol, 6, pp.303~ (2015)
36. HarriffMJ, "MR1 displays the microbial metabolome driving selective MR1-restricted T cell receptor usage", Sci Immunol, 3, pp.eaao2556~ (2018)
37. Lee Y, "Induction and molecular signature of pathogenic TH17 cells", Nat Immunol, 13, pp.991~999 (2012)
38. Lee JY, "Serum amyloid A proteins induce pathogenic Th17 cells and promote inflammatory disease", Cell, 180, pp.79~91 (2020)
39. Omenetti S, "The intestine harbors functionally distinct homeostatic tissue-resident and inflammatory Th17 cells", Immunity, 51, pp.77~89 (2019)
40. Geem D, "Specific microbiotainduced intestinal Th17 differentiation requires MHC class II but not GALT and mesenteric lymph nodes", J Immunol, 193, pp.431~438 (2014)
41. Yang Y, "Focused specificity of intestinal TH17 cells towards commensal bacterial antigens", Nature, 510, pp.152~156 (2014)
42. Sano T, "An IL-23R", IL-22 circuit regulates epithelial serum amyloid A to promote local effector Th17 responses, 2015, pp.163, 381~393
43. Brockmann L, "Regulation of TH17 cells and associated cytokines in wound healing, tissue regeneration, and carcinogenesis", Int J Mol Sci, 18, pp.E1033~ (2017)
44. Kempski J, "TH17 cell and epithelial cell crosstalk during inflammatory bowel disease and carcinogenesis", Front Immunol, 8, pp.1373~ (2017)
45. Kumar P, "Intestinal Interleukin-17 receptor signaling mediates reciprocal control of the gut microbiota and autoimmune inflammation", Immunity, 44, pp.659~671 (2016)
46. Chow J, "Pathobionts of the gastrointestinal microbiota and inflammatory disease", Curr Opin Immunol, 23, pp.473~480 (2011)
47. Xu M, "c-MAFdependent regulatory T cells mediate immunological tolerance to a gut pathobiont", Nature, 554, pp.373~377 (2018)
48. Kullberg MC, "IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis", J Exp Med, 203, pp.2485~2494 (2006)
49. Hue S, "Interleukin-23drives innate and T cell-mediated intestinal inflammation", J Exp Med, 203, pp.2473~2483 (2006)
50. Repoila F, "Adaptation of the gut pathobiont Enterococcus faecalis to deoxycholate and taurocholate bile acids", Sci Rep, 12, pp.8485~ (2022)
51. Balish E, "Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice", Am J Pathol, 160, pp.2253~2257 (2002)
52. Cahill RJ, "Inflammatory bowel disease : an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus", Infect Immun, 65, pp.3126~3131 (1997)
53. Ahern PP, "Interleukin-23 drives intestinal inflammation through direct activity on T cells", Immunity, 33, pp.279~288 (2010)
54. Neumann C, "c-Maf-dependent Treg cell control of intestinal TH17 cells and IgA establishes hostmicrobiota homeostasis", Nat Immunol, 20, pp.471~481 (2019)
55. Rutz S, "Transcription factor c-Maf mediates the TGF-β-dependent suppression of IL-22 production in T(H)17cells", Nat Immunol, 12, pp.1238~1245 (2011)
56. Gaublomme JT, "Single-cell genomics unveils critical regulators of Th17 cell pathogenicity", Cell, 163, pp.1400~1412 (2015)
57. Schnell A, "Stem-like intestinal Th17 cells give rise to pathogenic effector T cells during autoimmunity", Cell, 184, pp.6281~6298 (2021)
58. Satoh-Takayama N, "Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense", Immunity, 29, pp.958~970 (2008)
59. Melo-Gonzalez F, "Functional and phenotypic heterogeneity of group 3 innate lymphoid cells", Immunology, 150, pp.265~275 (2017)
60. Sanos SL, "RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells", Nat Immunol, 10, pp.83~91 (2009)
61. Jarade A, "Group 3 innate lymphoid cells mediate host defense against attaching and effacing pathogens", Curr Opin Microbiol, 63, pp.83~91 (2021)
62. Klose CS, "A T-bet gradient controls the fate and function of CCR6-RORγt+ innate lymphoid cells", Nature, 494, pp.261~265 (2013)
63. Diefenbach A, "Innate lymphoid cell-epithelial cell modules sustain intestinal homeostasis", Immunity, 52, pp.452~463 (2020)
64. Goto Y, "Innate lymphoid cells regulate intestinal epithelial cell glycosylation", Science, 345, pp.1254009~ (2014)
65. Talbot J, "Feeding-dependent VIP neuron-ILC3 circuit regulates the intestinal barrier", Nature, 579, pp.575~580 (2020)
66. Eckle SB, "Recognition of vitamin B precursors and byproducts by mucosal associated invariant T cells", J Biol Chem, 290, pp.30204~30211 (2015)
67. Amini A, "MAIT cells in barrier tissues : lessons from immediate neighbors", Front Immunol, 11, pp.584521~ (2020)
68. Constantinides MG, "MAIT cells are imprinted by the microbiota in early life and promote tissue repair", Science, 366, pp.eaax6624~ (2019)
69. Leng T, "TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions", Cell Reports, 28, pp.3077~3091 (2019)
70. Nel I, "MAIT cells, guardians of skin and mucosa", Mucosal Immunol, 14, pp.803~814 (2021)
71. Hinks TS, "MAIT cell activation and functions", Front Immunol, 11, pp.1014~ (2020)
72. Hoytema van Konijnenburg DP, "Intestinal epithelial and intraepithelial T cell crosstalk mediates a dynamic response to infection", Cell, 171, pp.783~794 (2017)
73. Agerholm R, "Evolved to protect, designed to destroy : IL-17-producing γδ T cells in infection, inflammation, and cancer", Eur J Immunol, 51, pp.2164~2177 (2021)
74. Duan J, "Microbial colonization drives expansion of IL-1 receptor 1-expressing and IL-17-producing γ", δ T cells, 2010, pp.7, 140~150
75. Chen YS, "IL-17-producing γδ T cells protect against Clostridium difficile infection", J Clin Invest, 130, pp.2377~2390 (2020)
76. Eberl M, "Antigen recognition by human γδ T cells : one step closer to knowing", Immunol Cell Biol, 98, pp.351~354 (2020)
77. Vaishnava S, "The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine", Science, 334, pp.255~258 (2011)
78. Ismail AS, "Gammadelta intraepithelial lymphocytes are essential mediators of host-microbial homeostasis at the intestinal mucosal surface", Proc Natl Acad Sci U S A, 108, pp.8743~8748 (2011)
79. Sag D, "Improved detection of cytokines produced by invariant NKT cells", Sci Rep, 7, pp.16607~ (2017)
80. Selvanantham T, "NKT cell–deficient mice harbor an altered microbiota that fuels intestinal inflammation during chemically induced colitis", J Immunol, 197, pp.4464~4472 (2016)
81. Olszak T, "Microbial exposure during early life has persistent effects on natural killer T cell function", Science, 336, pp.489~493 (2012)
82. Kushwah R, "Complexity of dendritic cell subsets and their function in the host immune system", Immunology, 133, pp.409~419 (2011)
83. Coombes JL, "A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β and retinoic acid-dependent mechanism", J Exp Med, 204, pp.1757~1764 (2007)
84. Diehl GE, "Microbiota restricts trafficking of bacteria to mesenteric lymph nodes by CX(3)CR1(hi)cells", Nature, 494, pp.116~120 (2013)
85. Panea C, "Intestinal monocyte-derived macrophages control commensal-specific Th17 responses", Cell Reports, 12, pp.1314~1324 (2015)
86. Guilliams M, "Dendritic cells, monocytes and macrophages : a unified nomenclature based on ontogeny", Nat Rev Immunol, 14, pp.571~578 (2014)
87. Hepworth MR, "Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4+ T cells", Science, 348, pp.1031~1035 (2015)
88. Sonnenberg GF, "Functional interactions between innate lymphoid cells and adaptive immunity", Nat Rev Immunol, 19, pp.599~613 (2019)
89. Biton M, "T helper cell cytokines modulate intestinal stem cell renewal and differentiation", Cell, 175, pp.1307~1320 (2018)
90. Goto Y, "Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation", Immunity, 40, pp.594~607 (2014)
91. Martínez-López M, "Microbiota sensing by Mincle-Syk axis in dendritic cells regulates interleukin-17 and-22 production and promotes intestinal barrier integrity", Immunity, 50, pp.446~461 (2019)
92. Segura E, "Human inflammatory dendritic cells induce Th17 cell differentiation", Immunity, 38, pp.336~348 (2013)
93. Hepworth MR, "Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria", Nature, 498, pp.113~117 (2013)
94. Kedmi R, "Antigen presentation by type 3 innate lymphoid cells instructs the differentiation of gut microbiotaspecific regulatory T cells", bioRxiv. 2021.11.19.469318, ~ (2021)
95. Melo-Gonzalez F, "Antigen-presenting ILC3 regulate T cell-dependent IgA responses to colonic mucosal bacteria", J Exp Med, 216, pp.728~742 (2019)
96. Lehmann FM, "Microbiota-induced tissue signals regulate ILC3-mediated antigen presentation", Nat Commun, 11, pp.1794~ (2020)
97. Gaudino SJ, "Cross-talk between antigen presenting cells and T cells impacts intestinal homeostasis, bacterial infections, and tumorigenesis", Front Immunol, 10, pp.360~ (2019)
98. Bland P, "MHC class II expression by the gut epithelium", Immunol Today, 9, pp.174~178 (1988)
99. Koyama M, "MHC class II antigen presentation by the intestinal epithelium initiates graftversus-host disease and is influenced by the microbiota", Immunity, 51, pp.885~898 (2019)
100. Jamwal DR, "Intestinal epithelial expression of MHCII determines severity of chemical, T-cell–induced, and infectious colitis in mice", Gastroenterology, 159, pp.1342~1356 (2020)
101. Stephens WZ, "Epithelial-myeloid exchange of MHC class II constrains immunity and microbiota composition", Cell Reports, 37, pp.109916~ (2021)
102. Ladinsky MS, "Endocytosis of commensal antigens by intestinal epithelial cells regulates mucosal T cell homeostasis", Science, 363, pp.eaat4042~ (2019)
103. Devlin AS, "A biosynthetic pathway for a prominent class of microbiota-derived bile acids", Nat Chem Biol, 11, pp.685~690 (2015)
104. Song X, "Microbial bile acid metabolites modulate gut RORγ+ regulatory T cell homeostasis", Nature, 577, pp.410~415 (2020)
105. Hang S, "Bile acid metabolites control TH17 and Treg cell differentiation", Nature, 576, pp.143~148 (2019)
106. Li W, "A bacterial bile acid metabolite modulates Treg activity through the nuclear hormone receptor NR4A1", Cell Host Microbe, 29, pp.1366~1377 (2021)
107. Kim CH, "Control of lymphocyte functions by gut microbiota-derived short-chain fatty acids", Cell Mol Immunol, 18, pp.1161~1171 (2021)
108. Furusawa Y, "Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells", Nature, 504, pp.446~450 (2013)
109. Luu M, "The short-chain fatty acid pentanoate suppresses autoimmunity by modulating the metabolicepigenetic crosstalk in lymphocytes", Nat Commun, 10, pp.760~ (2019)
110. Zhou L, "Faecalibacterium prausnitzii produces butyrate to maintain Th17", Treg balance and to ameliorate colorectal colitis by inhibiting Histone Deacetylase 1, 2018, pp.24, 1926~1940
111. Dupraz L, "Gut microbiota-derived short-chain fatty acids regulate IL-17 production by mouse and human intestinal γδ T cells", Cell Reports, 36, pp.109332~ (2021)
112. Chun E, "Metabolite-sensing receptor Ffar2 regulates colonic group 3 innate lymphoid cells and gut immunity", Immunity, 51, pp.871~884 (2019)
113. Agus A, "Gut microbiota regulation of tryptophan metabolism in health and disease", Cell Host Microbe, 23, pp.716~724 (2018)
114. Shinde R, "The aryl hydrocarbon receptor : Connecting immunity to the microenvironment", Trends Immunol, 39, pp.1005~1020 (2018)
115. Quintana FJ, "Control of T(reg)and T(H)17 cell differentiation by the aryl hydrocarbon receptor", Nature, 453, pp.65~71 (2008)
116. Veldhoen M, "Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells", J Exp Med, 206, pp.43~49 (2009)
117. Chinen I, "The aryl hydrocarbon receptor", microRNA-212, Int Immunol, pp.2015, 27[DOI]
118. Gagliani N, "Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation", Nature, 523, pp.221~225 (2015)
119. Ye J, "The aryl hydrocarbon receptor preferentially marks and promotes gut regulatory T cells", Cell Reports, 21, pp.2277~2290 (2017)
120. Xiong L, "Ahr-Foxp3-RORγt axis controls gut homing of CD4+ T cells by regulating GPR15", Sci Immunol, 5, pp.eaaz7277~ (2020)
121. Schiering C, "Feedback control of AHR signalling regulates intestinal immunity", Nature, 542, pp.242~245 (2017)
122. Davis TA, "Serum amyloid A promotes inflammation-associated damage and tumorigenesis in a mouse model of colitis-associated cancer", Cell Mol Gastroenterol Hepatol, 12, pp.1329~1341 (2021)
123. Gattu S, "Epithelial retinoic acid receptor β regulates serum amyloid A expression and vitamin A-dependent intestinal immunity", Proc Natl Acad Sci U S A, 116, pp.10911~10916 (2019)
124. Bang YJ, "Serum amyloid A delivers retinol to intestinal myeloid cells to promote adaptive immunity", Science, 373, pp.eabf9232~ (2021)
125. Caruso R, "Host-microbiota interactions in inflammatory bowel disease", Nat Rev Immunol, 20, pp.411~426 (2020)
126. Zhao J, "Th17 cells in inflammatory bowel disease : Cytokines, plasticity, and therapies", J Immunol Res, 2021, pp.8816041~ (2021)
127. Hovhannisyan Z, "Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases", Gastroenterology, 140, pp.957~965 (2011)
128. Quévrain E, "Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn’s disease", Gut, 65, pp.415~425 (2016)
129. Atarashi K, "Induction of colonic regulatory T cells by indigenous Clostridium species", Science, 331, pp.337~341 (2011)
130. Patterson AM, "Human gut symbiont Roseburia hominis promotes and regulates innate immunity", Front Immunol, 8, pp.1166~ (2017)
131. Glassner KL, "The microbiome and inflammatory bowel disease", J Allergy Clin Immunol, 145, pp.16~27 (2020)
132. Ryan FJ, "Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel disease", Nat Commun, 11, pp.1512~ (2020)
133. Mar JS, "Disease severity and immune activity relate to distinct interkingdom gut microbiome states in ethnically distinct ulcerative colitis patients", MBio, 7, pp.e01072~16 (2016)
134. Viljoen KS, "Quantitative profiling of colorectal cancerassociated bacteria reveals associations between fusobacterium spp., enterotoxigenic Bacteroides fragilis(ETBF)and clinicopathological features of colorectal cancer", PLoS One, 10, pp.e0119462~ (2015)
135. Chung L, "Bacteroides fragilis toxin coordinates a pro-carcinogenic inflammatory cascade via targeting of colonic epithelial cells", Cell Host Microbe, 23, pp.203~214 (2018)
136. Lo Presti E, "Characterization of γδT cells in intestinal mucosa from patients with early-onset or long-standing inflammatory bowel disease and their correlation with clinical status", J Crohn’s Colitis, 13, pp.873~883 (2019)
137. Sinha SR, "Dysbiosis-induced secondary bile acid deficiency promotes intestinal inflammation", Cell Host Microbe, 27, pp.659~670 (2020)
138. Zhu C, "Roseburia intestinalis inhibits interleukin-17 excretion and promotes regulatory T cells differentiation in colitis", Mol Med Rep, 17, pp.7567~7574 (2018)
139. Mazmanian SK, "An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system", Cell, 122, pp.107~118 (2005)
140. Mazmanian SK, "A microbial symbiosis factor prevents intestinal inflammatory disease", Nature, 453, pp.620~625 (2008)
141. Zamani S, "Detection of enterotoxigenic Bacteroides fragilis in patients with ulcerative colitis", Gut Pathog, 9, pp.53~ (2017)
142. Png CW, "Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria", Am J Gastroenterol, 105, pp.2420~2428 (2010)
143. Geuking MB, "Microbial modulation of intestinal T helper cell responses and implications for disease and therapy", Mucosal Immunol, 13, pp.855~866 (2020)
144. Joossens M, "Dysbiosis of the faecal microbiota in patients with Crohn’s disease and their unaffected relatives", Gut, 60, pp.631~637 (2011)
145. Khan I, "Alteration of gut microbiota in inflammatory bowel disease(IBD) : Cause or consequence? IBD treatment targeting the gut microbiome", Pathogens, 8, pp.E126~ (2019)
146. Bilsborough J, "Therapeutic targets in inflammatory bowel disease : current and future", The American Journal of Gastroenterology Supplements, 3, pp.27~37 (2016)
147. James KR, "Redefining intestinal immunity with single-cell transcriptomics", Mucosal Immunol, 15, pp.531~541 (2022)
148. Jaeger N, "Single-cell analyses of Crohn’s disease tissues reveal intestinal intraepithelial T cells heterogeneity and altered subset distributions", Nat Commun, 12, pp.1921~ (2021)
149. Martin JC, "Single-cell analysis of Crohn’s disease lesions identifies a pathogenic cellular module associated with resistance to anti-TNF therapy", Cell, 178, pp.1493~1508 (2019)
150. Li G, "Identification of novel population-specific cell subsets in Chinese Ulcerative Colitis patients using single-cell RNA sequencing", Cell Mol Gastroenterol Hepatol, 12, pp.99~117 (2021)
151. Smillie CS, "Intra-and inter-cellular rewiring of the human colon during Ulcerative Colitis", Cell, 178, pp.714~730 (2019)
152. Bigaeva E, "Understanding human gut diseases at singlecell resolution", Hum Mol Genet, 29(R1), pp.R51~R58 (2020)
153. Kameyama H, "Genomic characterization of colitis-associated colorectal cancer", World J Surg Oncol, 16, pp.121~ (2018)
154. Ning C, "Complement activation promotes colitis-associated carcinogenesis through activating intestinal IL-1β", IL-17A axis, 2015, pp.8, 1275~1284
155. Baxter NT, "Structure of the gut microbiome following colonization with human feces determines colonic tumor burden", Microbiome, 2, pp.20~ (2014)
156. Ahn J, "Human gut microbiome and risk for colorectal cancer", J Natl Cancer Inst, 105, pp.1907~1911 (2013)
157. Richard ML, "Mucosa-associated microbiota dysbiosis in colitis associated cancer", Gut Microbes, 9, pp.131~142 (2018)
158. Shao X, "Bacteroides fragilis restricts colitis-associated cancer via negative regulation of the NLRP3 axis", Cancer Lett, 523, pp.170~181 (2021)
159. Wang Z, "Protective role of fecal microbiota transplantation on colitis and colitis-associated colon cancer in mice is associated with Treg cells", Front Microbiol, 10, pp.2498~ (2019)
160. Panaccione R, "Briakinumab for treatment of Crohn’s disease : results of a randomized trial", Inflamm Bowel Dis, 21, pp.1329~1340 (2015)
161. Ito H, "A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn’s disease", Gastroenterology, 126, pp.989~996 (2004)
162. Targan SR, "Mo2083 a randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and efficacy of AMG 827 in subjects with moderate to severe Crohn’s disease", Gastroenterology, 143, pp.e26~ (2012)
163. Sandborn WJ, "A randomized trial of Ustekinumab, a human interleukin-12", 23 monoclonal antibody, in patients with moderate-to-severe Crohn’s disease, 2008, pp.135, 1130~1141
164. Cai Z, "Treatment of inflammatory bowel disease: a comprehensive review", Front Med(Lausanne), 8, pp.765474~ (2021)
165. Henn MR, "A phase 1b safety study of SER-287, a spore-based microbiome therapeutic, for active mild to moderate ulcerative colitis", Gastroenterology, 160, pp.115~127 (2021)
166. Silber J, "Randomized, double-blind, placebo (PBO)-controlled, single- and multiple-dose phase 1 study of VE202, a defined bacterial consortium for treatment of IBD: safety and colonization dynamics of a novel live biotherapeutic product (LBP) in healthy adults", Inflamm Bowel Dis, 28(Suppl 1), pp.S65~S66 (2022)

관련 논문AI추천